Tuesday, April 17, 2007

This and That (Mostly That)

Some thoughts for the VIXophile in all of us:


…and the AndMoreophile too:


Finally, some have wondered what I did about my ‘all in’ bet on VRTX last Friday for the CNBC Million Dollar Portfolio Challenge. Well, I took a beating on Friday and for the better part of yesterday, but when it rallied to almost fill the gap late yesterday, I decided to hold on rather than jump into an earnings play, so my patience is being rewarded today. My thinking was along the lines that I always look very closely at the second day of price action after announcements of FDA decisions or key clinical data for biotechnology companies; I saw yesterday's reversal as an opportunity not only to confirm a 15 month low, but signal the 10+ million short shares that it was time to cover. While I may make a little money today, I am not closing the gap on the leaders and time is becoming my enemy. Now it looks like it is time to roll the earnings dice

1 comments:

Unknown said...

I went all in TOA recently. It also has a massive short position.

DISCLAIMER: "VIX®" is a trademark of Chicago Board Options Exchange, Incorporated. Chicago Board Options Exchange, Incorporated is not affiliated with this website or this website's owner's or operators. CBOE assumes no responsibility for the accuracy or completeness or any other aspect of any content posted on this website by its operator or any third party. All content on this site is provided for informational and entertainment purposes only and is not intended as advice to buy or sell any securities. Stocks are difficult to trade; options are even harder. When it comes to VIX derivatives, don't fall into the trap of thinking that just because you can ride a horse, you can ride an alligator. Please do your own homework and accept full responsibility for any investment decisions you make. No content on this site can be used for commercial purposes without the prior written permission of the author. Copyright © 2007-2023 Bill Luby. All rights reserved.
 
Web Analytics